                                                                                                                                                                    I




                                                                   113TH CONGRESS
                                                                      1ST SESSION                           H. R. 225
                                                                   To amend title IV of the Public Health Service Act to provide for a National
                                                                       Pediatric Research Network, including with respect to pediatric rare
                                                                       diseases or conditions.




                                                                                 IN THE HOUSE OF REPRESENTATIVES
                                                                                                 JANUARY 14, 2013
                                                                   Mrs. CAPPS (for herself, Mrs. MCMORRIS RODGERS, Ms. DEGETTE, Mr. HAR-
                                                                       PER, Ms. MATSUI, and Mr. KING of New York) introduced the following
                                                                       bill; which was referred to the Committee on Energy and Commerce




                                                                                                             A BILL
                                                                   To amend title IV of the Public Health Service Act to
                                                                      provide for a National Pediatric Research Network, in-
                                                                      cluding with respect to pediatric rare diseases or condi-
                                                                      tions.
                                                                     1               Be it enacted by the Senate and House of Representa-
                                                                     2 tives of the United States of America in Congress assembled,
                                                                     3     SECTION 1. SHORT TITLE.
                                                                     4               This Act may be cited as the ‘‘National Pediatric Re-
rfrederick on DSK6VPTVN1PROD with                                    5 search Network Act of 2013’’.
                                                                     1     SEC. 2. NATIONAL PEDIATRIC RESEARCH NETWORK.       2
                                                                     2               Section 409D of the Public Health Service Act (42
                                                                     3 U.S.C. 284h; relating to the Pediatric Research Initiative)
                                                                     4 is amended—
                                                                     5                        (1) by redesignating subsection (d) as sub-
                                                                     6               section (f); and
                                                                     7                        (2) by inserting after subsection (c) the fol-
                                                                     8               lowing:
                                                                     9               ‘‘(d) NATIONAL PEDIATRIC RESEARCH NETWORK.—
                                                                   10                         ‘‘(1) NETWORK.—In carrying out the Initiative,
                                                                   11                the Director of NIH, acting through the Director of
                                                                   12                the Eunice Kennedy Shriver National Institute of
                                                                   13                Child Health and Human Development and in col-
                                                                   14                laboration with other appropriate national research
                                                                   15                institutes and national centers that carry out activi-
                                                                   16                ties involving pediatric research, may provide for the
                                                                   17                establishment of a National Pediatric Research Net-
                                                                   18                work consisting of the pediatric research consortia
                                                                   19                receiving awards under paragraph (2).
                                                                   20                         ‘‘(2) PEDIATRIC                 RESEARCH CONSORTIA.—

                                                                   21                                  ‘‘(A) IN         GENERAL.—The                     Director of the
                                                                   22                         Institute may award funding, including through
                                                                   23                         grants, contracts, or other mechanisms, to pub-
rfrederick on DSK6VPTVN1PROD with                                  24                         lic or private nonprofit entities—
                                                                                •HR 225 IH

                                                                                                                              3
                                                                     1                                         ‘‘(i) for planning, establishing, or
                                                                     2                                 strengthening pediatric research consortia;
                                                                     3                                 and
                                                                     4                                         ‘‘(ii) for providing basic operating
                                                                     5                                 support for such consortia, including with
                                                                     6                                 respect to—
                                                                     7                                                  ‘‘(I) basic, clinical, behavioral, or
                                                                     8                                         translational research to meet unmet
                                                                     9                                         needs for pediatric research; and
                                                                   10                                                   ‘‘(II) training researchers in pe-
                                                                   11                                          diatric research techniques in order to
                                                                   12                                          address            unmet            pediatric        research
                                                                   13                                          needs.
                                                                   14                                  ‘‘(B) RESEARCH.—The Director of NIH
                                                                   15                         shall ensure that—
                                                                   16                                          ‘‘(i) each consortium receiving an
                                                                   17                                  award under subparagraph (A) conducts or
                                                                   18                                  supports at least one category of research
                                                                   19                                  described in subparagraph (A)(ii)(I) and
                                                                   20                                  collectively such consortia conduct or sup-
                                                                   21                                  port all such categories of research; and
                                                                   22                                          ‘‘(ii) one or more such consortia pro-
                                                                   23                                  vide training described in subparagraph
rfrederick on DSK6VPTVN1PROD with                                  24                                  (A)(ii)(II).
                                                                                •HR 225 IH

                                                                                                                              4
                                                                     1                                 ‘‘(C) NUMBER               OF CONSORTIA.—The                 Direc-
                                                                     2                        tor of NIH may make awards under this para-
                                                                     3                        graph for not more than 20 pediatric research
                                                                     4                        consortia.
                                                                     5                                 ‘‘(D) ORGANIZATION                        OF CONSORTIUM.—
                                                                     6                        Each consortium receiving an award under sub-
                                                                     7                        paragraph (A) shall—
                                                                     8                                         ‘‘(i) be formed from a collaboration of
                                                                     9                                 cooperating institutions;
                                                                   10                                          ‘‘(ii) be coordinated by a lead institu-
                                                                   11                                  tion;
                                                                   12                                          ‘‘(iii) agree to disseminate scientific
                                                                   13                                  findings, including from clinical trials, rap-
                                                                   14                                  idly and efficiently; and
                                                                   15                                          ‘‘(iv) meet such requirements as may
                                                                   16                                  be prescribed by the Director of NIH.
                                                                   17                                  ‘‘(E) SUPPLEMENT,                     NOT SUPPLANT.—Any
                                                                   18                         support received by a consortium under sub-
                                                                   19                         paragraph (A) shall be used to supplement, and
                                                                   20                         not supplant, other public or private support for
                                                                   21                         activities authorized to be supported under this
                                                                   22                         paragraph.
                                                                   23                                  ‘‘(F) DURATION                 OF SUPPORT.—Support               of
rfrederick on DSK6VPTVN1PROD with                                  24                         a consortium under subparagraph (A) may be
                                                                   25                         for a period of not to exceed 5 years. Such pe-


                                                                                •HR 225 IH

                                                                                                                              5
                                                                     1                        riod may be extended at the discretion of the
                                                                     2                        Director of NIH.
                                                                     3                        ‘‘(3) COORDINATION                          OF     CONSORTIA          ACTIVI-
                                                                     4               TIES.—The             Director of NIH shall—
                                                                     5                                 ‘‘(A) as appropriate, provide for the coordi-
                                                                     6                        nation of activities (including the exchange of
                                                                     7                        information and regular communication) among
                                                                     8                        the consortia established pursuant to paragraph
                                                                   109                        (2); and ‘‘(B) require the periodic preparation and
                                                                   11                         submission to the Director of reports on the ac-
                                                                   12                         tivities of each such consortium.
                                                                   13                         ‘‘(4) ASSISTANCE                      WITH          REGISTRIES.—Each
                                                                   14                consortium receiving an award under paragraph
                                                                   15                (2)(A) shall provide assistance to the Centers for
                                                                   16                Disease Control and Prevention in the establishment
                                                                   17                or expansion of patient registries and other surveil-
                                                                   18                lance systems as appropriate and upon request by
                                                                   19                the Director of the Centers.
                                                                   20                ‘‘(e) RESEARCH                 ON    PEDIATRIC RARE DISEASES                       OR
                                                                   21 CONDITIONS.—
                                                                   22                         ‘‘(1) IN        GENERAL.—In                    making awards under
                                                                   23                subsection (d)(2) for pediatric research consortia,
rfrederick on DSK6VPTVN1PROD with                                  24                the Director of NIH shall ensure that an appro-
                                                                                •HR 225 IH

                                                                                                                              6
                                                                     1               priate number of such awards are awarded to such
                                                                     2               consortia that agree to—
                                                                     3                                 ‘‘(A) focus primarily on pediatric rare dis-
                                                                     4                        eases or conditions (including any such diseases
                                                                     5                        or conditions that are genetic disorders (such as
                                                                     6                        spinal muscular atrophy and Duchenne mus-
                                                                     7                        cular dystrophy) or are related to birth defects
                                                                     8                        (such as Down syndrome and fragile X)); and
                                                                     9                                 ‘‘(B) conduct or coordinate one or more
                                                                   10                         multisite clinical trials of therapies for, or ap-
                                                                   11                         proaches to, the prevention, diagnosis, or treat-
                                                                   12                         ment of one or more pediatric rare diseases or
                                                                   13                         conditions.
                                                                   14                         ‘‘(2) DATA           COORDINATING CENTER.—

                                                                   15                                  ‘‘(A)        ESTABLISHMENT.—In                               connection
                                                                   16                         with support of consortia described in para-
                                                                   17                         graph (1), the Director of NIH shall establish
                                                                   18                         a data coordinating center for the following
                                                                   19                         purposes:
                                                                   20                                          ‘‘(i) To distribute the scientific find-
                                                                   21                                  ings referred to in paragraph (1)(C).
                                                                   22                                          ‘‘(ii) To provide assistance in the de-
                                                                   23                                  sign and conduct of collaborative research
rfrederick on DSK6VPTVN1PROD with                                  24                                  projects and the management, analysis,
                                                                                •HR 225 IH

                                                                                                                              7
                                                                     1                                 and storage of data associated with such
                                                                     2                                 projects.
                                                                     3                                         ‘‘(iii)        To          organize           and    conduct
                                                                     4                                 multisite monitoring activities.
                                                                     5                                 ‘‘(B) REPORTING.—The Director of NIH
                                                                     6                        shall—
                                                                     7                                         ‘‘(i) require the data coordinating cen-
                                                                     8                                 ter established under subparagraph (A) to
                                                                     9                                 provide regular reports to the Director of
                                                                   10                                  NIH and the Commissioner of Food and
                                                                   11                                  Drugs on research conducted by consortia
                                                                   12                                  described in paragraph (1), including infor-
                                                                   13                                  mation on enrollment in clinical trials and
                                                                   14                                  the allocation of resources with respect to
                                                                   15                                  such research; and
                                                                   16                                          ‘‘(ii) as appropriate, incorporate infor-
                                                                   17                                  mation reported under clause (i) into the
                                                                   18                                  Director’s biennial reports under section
                                                                   19                                  403.’’.            Æ
rfrederick on DSK6VPTVN1PROD with




                                                                                •HR 225 IH

